Czechia, March 17 -- Czechia based ROCHE s.r.o. has secured contract from Fakultni nemocnice Hradec Kralove for Antineoplastics Agans - Pertuzumab and Trastuzumab Emtansine Medicinal Products. The value of the contract is worth 3454636060 CZK.
Published by HT Digital Content Services with permission from Pivotal Sources....